No products in your basket.
Purchase your test with
Price range: £499.00 through £559.00
VERAgene NIPT is a broad prenatal screening test available from 10 weeks of pregnancy. It combines maternal blood with a Buccal Cheek Swab from the biological father, allowing one test to screen for common trisomies, selected sex chromosome conditions, selected microdeletion syndromes and 100 selected conditions caused mainly by one gene.
This combined scope makes VERAgene a useful option if you want more than chromosome-only screening without having to compare several test levels. Through My DNA Lab, you can access the test privately and use the report to support an informed conversation with your midwife, GP or obstetric team.
A qualified healthcare professional must collect the maternal blood sample. You can arrange this locally or use My DNA Lab’s mobile phlebotomy service within mainland UK. The biological father can collect his Buccal Cheek Swab from the comfort of home. Once both samples are ready, contact us and we will arrange their return together.
During pregnancy, small pieces of DNA from the placenta circulate in the pregnant woman’s blood. This is called cell-free DNA. VERAgene analyses this DNA alongside genetic information from the biological father to screen for:
The paternal sample helps the laboratory assess selected recessive and X-linked conditions in the panel. Because these conditions follow different inheritance patterns, using information from both biological parents adds context to this part of the screen. You can review all 100 conditions in the VERAgene list under ‘Test provider and further information’ further down this page.
However, VERAgene remains a screening test rather than a diagnosis. It does not assess every chromosome condition, every condition caused by one gene or every possible gene change. Prader-Willi and Angelman screening is limited to the 15q11.2-q13 deletion, while Cri-du-chat screening is limited to qualifying deletions within 5p.
VERAgene may suit you from 10 weeks of pregnancy if you want one broad screen covering both selected chromosome and single-gene conditions, and both the maternal blood sample and the biological father’s Buccal Cheek Swab can be provided.
If you know that you are expecting twins or triplets, the pregnancy has involved a vanishing twin, or donor eggs or sperm, IVF or a surrogate are involved, contact My DNA Lab before purchasing. We can confirm the current eligibility and sample requirements. If a genetic condition is already known in either family, a focused diagnostic test may provide a clearer answer than a broad screen.
Both samples are required because they support different parts of the analysis. For that reason, do not omit a sample or replace it with a sample from another person.
Your report gives a screening result for every condition included in the VERAgene panel. A lower-chance result makes an included condition less likely, while a higher-chance result means that further assessment may be needed; neither result provides a diagnosis.
We always recommend that you discuss your results with your healthcare professional. Share a higher-chance or unclear result promptly with your midwife or obstetric team so they can consider it alongside ultrasound findings and other pregnancy information, and discuss diagnostic testing such as CVS or amniocentesis where appropriate.
After a higher-chance result, you can request an additional written report from the provider free of charge, although it is not issued automatically. A telephone consultation with the provider is also available for €150, subject to change. Contact My DNA Lab and we will explain how to request either form of support. Your maternity team remains responsible for pregnancy care and any further diagnostic testing.
A lower-chance result does not provide a general guarantee of a baby’s health. For example, the cause of a scan finding or a condition already present in the family may sit outside the genes and types of change covered by VERAgene.
The main difference from chromosome-only NIPT is the combined scope. VERAgene uses maternal blood and the biological father’s Buccal Cheek Swab to screen for selected chromosome conditions and a fixed list of single-gene conditions. By comparison, a chromosome-only NIPT may be simpler if you want screening limited to common trisomies.
Broader screening can provide additional information, but it can also produce findings that are harder to explain or require further testing. VERAgene also depends on both samples being returned together. If the biological father cannot provide a sample, contact My DNA Lab so we can explain which other NIPT options may be available.
If a scan, family history or previous pregnancy points to a particular condition, share that information with your maternity or genetics team. A targeted diagnostic test asks a more specific question and may therefore be more informative than VERAgene in that situation.
Whatever result VERAgene provides, continue all routine antenatal appointments, scans and screening offered by your maternity team.
